Search

Studies conducted in mice reveal a potential way to breach the defenses of pancreatic cancer tumors.

… Tuesday, March 31, 2020 Summary In a study published March 31, researchers at the Sloan Kettering Institute report that a two-drug combination makes pancreatic cancer more sensitive to immunotherapy in mouse models. Pancreatic cancer is one of the most challenging cancers to treat. In part, that’s because

Learn how highly focused, intense radiation can stop lung cancer from growing after it has spread to a small number of sites.

… Thursday, December 14, 2023 Non-small cell lung cancer (NSCLC) , the most common form of lung cancer , is often diagnosed at an advanced  stage . About half the time, it has already spread around the body and has reached stage 4. The standard treatment for most patients with metastatic NSCLC is systemic

Obtenga información sobre cómo la radiación intensamente focalizada y de alta dosis puede detener el crecimiento del cáncer pulmonar después de que se ha diseminado a una pequeña cantidad de sitios.

… Thursday, December 14, 2023 El cáncer pulmonar de células no pequeñas (CPCNP) , la forma más común de cáncer pulmonar , suele diagnosticarse en un estadio  avanzado . Aproximadamente la mitad de las veces, ya se ha diseminado por el cuerpo y ha alcanzado el estadio 4. El tratamiento convencional para

Meet David, a patient representative at MSK, who makes his voice heard is as a member of MSK’s LGBTQ Clinical Advisory Committee. Founded in 2017, the committee advises MSK staff on the clinical care of LGBTQ patients and provides strategic direction for the advancement of care for LGBTQ populations.

… Tuesday, June 29, 2021 For David Jay Smith, coming out was like Dorothy entering Oz. “My world went from black and white to Technicolor,” says David, who works at Memorial Sloan Kettering as a patient representative. “It was a transformative experience.” David knew at a young age he was “different” but

Patients like Michelle benefit from the specialized skills of experts in MSK’s Rare Breast Cancer Program.

… Thursday, October 5, 2023 It all happened so fast, says Michelle Villagomez. During a mammogram in February 2022 to check out a grape-sized lump in her right breast, the medical staff told Michelle to stay for an ultrasound. Then the radiologist pulled her aside and urged her to see an oncologist. “I

Research fellow Shaniqua Hayes joined the Jason Lewis Lab at the Sloan Kettering Institute (SKI) and Memorial Hospital about a year ago, after attending an online postdoc recruiting event and picking up “good vibes” about SKI.

… Friday, September 30, 2022 Research fellow Shaniqua Hayes Shaniqua Hayes joined the Jason Lewis Lab Jason Lewis Lab at the  Sloan Kettering Institute (SKI) Sloan Kettering Institute (SKI)  and Memorial Hospital about a year ago, after attending an online postdoc recruiting event and picking up “good

In a pivotal move to revolutionize the clinical research landscape, the MSK Clinical Research Innovation Consortium (CRIC) held its inaugural kick-off meeting in November 2025. Spearheaded by founding member MSK, the meeting welcomed new CRIC members Moffitt Cancer Center, Huntsman Cancer Institute, and the Tisch Cancer Center of Mount Sinai Health System.

… Friday, March 6, 2026 In a pivotal move to revolutionize the clinical research landscape, the MSK Clinical Research Innovation Consortium ( CRIC ) held its inaugural kick-off meeting in November 2025. Spearheaded by founding member MSK, the meeting welcomed new CRIC members Moffitt Cancer Center, Huntsman

In contrast with the findings of two international trials, Memorial Sloan Kettering Cancer Center data suggest the standard treatment – primary debulking surgery – may provide better outcomes in select patients when compared to neoadjuvant chemotherapy.

… Friday, September 16, 2016 Due to the lack of effective screening and disease-specific symptoms, ovarian cancer is often diagnosed at an advanced stage, after malignant cells have already spread to the visceral and parietal peritoneum, resulting in peritoneal carcinomatosis characterized by widespread

Memorial Sloan Kettering Cancer Center (MSK) today announced a $50 million gift from Jane and Daniel Och to advance MSK’s cutting-edge patient-care and research.

… Monday, June 9, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced a $50 million gift from Jane and Daniel Och to advance MSK’s cutting-edge patient-care and research. The majority of this gift will go towards supporting the development of MSK’s state-of-the-art cancer care facility, The

Learn how MSK doctors deliver intense doses of radiation with great precision using MRI guidance.

… Tuesday, September 12, 2023 An experimental prostate cancer treatment uses MRI to target radiation and intensify the dose to the tumor — and at the same time reduce side effects.     It’s more precise because MSK radiation oncologists take multiple MRI images during the procedure to adjust for tumor